CRHR1 rs242939: Genetics, Stress Response, and Cortisol
The genetic variant rs242939 is a single nucleotide polymorphism located within the CRHR1 gene, which encodes the corticotropin-releasing hormone receptor 1. This gene plays a pivotal role in the human stress response by modulating the hypothalamic-pituitary-adrenal (HPA) axis. Research suggests rs242939 forms part of a haplotype associated with altered cortisol reactivity and differences in vulnerability to stress.
What each genotype means
Typical cortisol response
You carry two copies of the common G allele in the CRHR1 gene, which is typically considered the reference genotype in stress reactivity studies. Research suggests this profile is associated with standard cortisol output during acute psychological stress challenges, without the attenuated reactivity observed in minor allele carriers. Evidence evaluating these specific hormonal differences remains limited and shows variability across different ancestral groups.
Carried by roughly 30% to 50% of individuals in most outbred populations, including European and African ancestries.
Moderately attenuated stress response
Carrying one copy of the A allele places you in an intermediate category for corticotropin-releasing hormone receptor 1 reactivity. Some research links this variant and its surrounding haplotype to modest reductions in peak salivary cortisol following acute psychosocial stress, though studies also note mixed findings across clinical cohorts. If you are discussing stress-related health or psychiatric medications with a healthcare provider, dosage decisions should always be directed by clinical guidance rather than this marker.
Carried by approximately 40% to 50% of individuals across European, Hispanic, and African populations.
Blunted cortisol reactivity
Having two copies of the A allele has been linked in preliminary studies to lower peak cortisol release and reduced total hormone output during acute psychosocial stress tests. This genotype forms part of a CRHR1 haplotype hypothesized to confer a degree of physiological buffering against stress-induced hypothalamic-pituitary-adrenal axis activation, although current published evidence remains limited. Because individual stress regulation is multifactorial, this genotype does not replace clinical assessment or dictate medical care.
Found in approximately 10% to 20% of people of European and Hispanic ancestry, and less commonly in East Asian cohorts.
Genomic Location and the CRHR1 Gene
The single nucleotide polymorphism rs242939 is situated on chromosome 17 within an intronic region of the corticotropin-releasing hormone receptor 1 (CRHR1) gene. The CRHR1 locus encodes a G-protein coupled receptor that exhibits high affinity for corticotropin-releasing hormone (CRH). When the hypothalamus detects psychological or physical stress, it releases CRH, which binds to CRHR1 on anterior pituitary cells. This triggers the cascade that prompts the release of adrenocorticotropic hormone (ACTH), eventually causing the adrenal cortex to produce cortisol. Because rs242939 is located in an intron, it does not alter the primary amino acid sequence of the receptor itself. Instead, it is thought to participate in regulatory complexes or serve as a linkage marker for non-coding variations that influence gene transcription, alternative splicing, or chromatin architecture. Along with adjacent polymorphisms in the CRHR1 gene, rs242939 constitutes a linkage disequilibrium block that researchers frequently examine in candidate gene studies evaluating neuroendocrine regulation.
The Biological Function in Stress Signaling
The hypothalamic-pituitary-adrenal axis serves as the body's primary neuroendocrine mechanism for coping with stressors. Upon activation, CRHR1-mediated signaling drives rapid systemic adaptations, ranging from altered metabolic pathways and increased cardiovascular activity to focused behavioral vigilance. Proper receptor activity ensures a sharp rise in cortisol when a threat appears, followed by prompt negative feedback to bring hormone levels back to baseline. Polymorphisms across the CRHR1 locus have been hypothesized to modify this sensitivity. When receptor expression or intracellular signaling cascades are subtly shifted by genetic background, the amplitude or duration of the hormonal stress response can change. In laboratory models and human cohort studies, variation across CRHR1 has been linked with differences in peak cortisol output and autonomic reactivity during acute psychological challenges. Consequently, CRHR1 functions as a key molecular bridge between external emotional stimuli and downstream systemic endocrine responses.
Scientific Evidence: Stress Reactivity and HPA Dynamics
Published candidate gene studies have evaluated rs242939 primarily in the context of acute psychosocial stress challenges and psychiatric vulnerability. In human experimental protocols such as the Trier Social Stress Test (TSST), specific CRHR1 haplotypes harboring rs242939 alleles have been associated with attenuated cortisol output following acute stress, pointing toward a possible buffering effect against excessive neuroendocrine activation. Other research groups have investigated rs242939 in relation to major depressive disorder, early-life adversity, and antidepressant treatment trajectories. However, the scientific evidence supporting these associations remains limited and inconsistent across broader genome-wide association studies (GWAS). Many early candidate gene findings suffer from modest sample sizes, moderate effect sizes, and failure to reach strict genome-wide statistical significance. Furthermore, gene-by-environment interactions—such as childhood trauma or chronic ambient stress—appear to heavily moderate the statistical signal of rs242939, meaning its observable physiological impact is contingent on environmental context rather than deterministic.
Population Distribution and Haplotype Structure
The alleles for rs242939 are typically designated as A (adenine) and G (guanine). In outbred global populations cataloged in databases such as dbSNP and gnomAD, the minor allele frequency fluctuates significantly across ancestries. The A allele generally presents at frequencies between 30% and 45% in European, American, and certain African cohorts, but can differ in Asian reference populations where allele distributions display notable divergence. Because the CRHR1 locus contains long stretches of linkage disequilibrium, rs242939 is rarely analyzed entirely in isolation. Instead, it is frequently evaluated as part of a multi-SNP haplotype alongside other well-studied variants such as rs110402 and rs242941. These shared haplotype blocks make it challenging to disentangle whether rs242939 directly drives functional changes in cortisol response or merely tags a broader ancestral chromosomal segment that encompasses functional regulatory elements elsewhere in the locus.
Translating Research to Real-World Application
Learning your rs242939 genotype offers interesting educational insight into neuroendocrine genetics, but it cannot be used to diagnose, predict, or treat any medical or psychiatric condition. Complex traits such as stress tolerance, anxiety susceptibility, and depression involve hundreds of genetic loci interacting alongside social, developmental, and environmental factors. Possessing a genotype linked in some studies to altered cortisol response does not mean an individual is clinically vulnerable to stress-related illness, nor does it guarantee resilience. Furthermore, while the CRHR1 locus has been studied in exploratory pharmacogenetic settings—such as research into corticosteroid efficacy in respiratory conditions or response to specific antidepressants—rs242939 is not an actionable clinical biomarker recognized by the Clinical Pharmacogenetics Implementation Consortium (CPIC). Individuals should never alter, stop, or initiate medications based on their genotype and should discuss all health questions and stress management strategies with qualified healthcare professionals.
How common is this variant?
The minor allele frequency for rs242939 generally ranges between 0.30 and 0.45 across outbred global populations, though specific genotype frequencies vary across different ancestral backgrounds.
Frequently asked questions
What does the rs242939 variant do in the body?
The rs242939 variant is an intronic marker located in the CRHR1 gene, which provides instructions for a receptor that initiates the body's cortisol release during stress. Research suggests it may influence the sensitivity of the stress response system, though it does not directly alter the receptor's protein structure.
Does having the rs242939 variant mean I handle stress poorly?
No, having a specific genotype at rs242939 does not mean you cannot cope with stress. Human stress resilience is a complex trait shaped primarily by lifestyle, coping skills, support systems, and numerous genetic factors working together.
Can rs242939 determine my risk for depression or anxiety?
Current scientific evidence is too limited and preliminary for rs242939 to be used as a predictive tool for depression or anxiety. While some research shows modest statistical associations in specific cohorts, it cannot diagnose or forecast psychiatric conditions.
Should I change my medications based on my rs242939 result?
No. The rs242939 variant is not recognized by clinical pharmacogenetics guidelines as an actionable marker for drug dosing or selection. Always consult your prescribing physician or pharmacist before making any changes to your medication.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs242939?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CRHR1
HPA-axis modulating variant in CRHR1 that interacts with psychosocial stress exposure to affect emotional reactivity and stress-coping traits.
Key intronic polymorphism in the corticotropin-releasing hormone receptor 1 gene that moderates endocrine and emotional vulnerability after exposure to early life trauma.
Polymorphism within the CRHR1 locus tagged to haplotypes modulating cortisol release during the Trier Social Stress Test.
Variant in the corticotropin-releasing hormone receptor 1 gene that moderates hypothalamic-pituitary-adrenal axis reactivity and vulnerability to stress-induced mood disturbances.
Intronic CRHR1 variant associated with neuroendocrine stress sensitivity.
Tag variant in the CRHR1 locus associated with HPA axis regulation.